USP22 and cancer: As USP22 deletions occur frequently and are associated with reduced patient survival in multiple cancer types, this study indicates that reduced USP22 expression and aberrant H2Bub1 regulation in tumors may drive genetic heterogeneity and promote cancer pathogenesis.